224 related articles for article (PubMed ID: 22102918)
21. The pncA gene from naturally pyrazinamide-resistant Mycobacterium avium encodes pyrazinamidase and confers pyrazinamide susceptibility to resistant M. tuberculosis complex organisms.
Sun Z; Scorpio A; Zhang Y
Microbiology (Reading); 1997 Oct; 143 ( Pt 10)():3367-3373. PubMed ID: 9353938
[TBL] [Abstract][Full Text] [Related]
22. Correlation of pncA sequence with pyrazinamide resistance level in BACTEC for 21 mycobacterium tuberculosis clinical isolates.
Mestdagh M; Realini L; Fonteyne PA; Rossau R; Jannes G; Mijs W; DE Smet KA; Portaels F; Van den Eeckhout E
Microb Drug Resist; 2000; 6(4):283-7. PubMed ID: 11272256
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of methods for testing the susceptibility of clinical Mycobacterium tuberculosis isolates to pyrazinamide.
Cui Z; Wang J; Lu J; Huang X; Zheng R; Hu Z
J Clin Microbiol; 2013 May; 51(5):1374-80. PubMed ID: 23390285
[TBL] [Abstract][Full Text] [Related]
24. Reevaluation of the critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide using wild-type MIC distributions and pncA gene sequencing.
Werngren J; Sturegård E; Juréen P; Ängeby K; Hoffner S; Schön T
Antimicrob Agents Chemother; 2012 Mar; 56(3):1253-7. PubMed ID: 22203587
[TBL] [Abstract][Full Text] [Related]
25. Characterisation of the pncA gene in Mycobacterium tuberculosis isolates from Gauteng, South Africa.
Bishop KS; Blumberg L; Trollip AP; Smith AN; Roux L; York DF; Kiepiela P
Int J Tuberc Lung Dis; 2001 Oct; 5(10):952-7. PubMed ID: 11605890
[TBL] [Abstract][Full Text] [Related]
26. New mutations in pncA of in vitro selected pyrazinamide-resistant strains of Mycobacterium tuberculosis.
Bamaga M; Zhang H; Wright DJ
Microb Drug Resist; 2001; 7(3):223-8. PubMed ID: 11759083
[TBL] [Abstract][Full Text] [Related]
27. Non-
Werngren J; Alm E; Mansjö M
J Clin Microbiol; 2017 Jun; 55(6):1920-1927. PubMed ID: 28404681
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.
Pang Y; Zhu D; Zheng H; Shen J; Hu Y; Liu J; Zhao Y
BMC Infect Dis; 2017 Nov; 17(1):711. PubMed ID: 29110640
[TBL] [Abstract][Full Text] [Related]
29. Pyrazinamide Susceptibility and
Rahman A; Ferdous SS; Ahmed S; Rahman SMM; Uddin MKM; Pholwat S; Gratz J; Houpt E; Banu S
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630193
[TBL] [Abstract][Full Text] [Related]
30. Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study.
Miotto P; Cabibbe AM; Feuerriegel S; Casali N; Drobniewski F; Rodionova Y; Bakonyte D; Stakenas P; Pimkina E; Augustynowicz-Kopeć E; Degano M; Ambrosi A; Hoffner S; Mansjö M; Werngren J; Rüsch-Gerdes S; Niemann S; Cirillo DM
mBio; 2014 Oct; 5(5):e01819-14. PubMed ID: 25336456
[TBL] [Abstract][Full Text] [Related]
31. Overcoming the Challenges of Pyrazinamide Susceptibility Testing in Clinical Mycobacterium tuberculosis Isolates.
Mok S; Roycroft E; Flanagan PR; Montgomery L; Borroni E; Rogers TR; Fitzgibbon MM
Antimicrob Agents Chemother; 2021 Jul; 65(8):e0261720. PubMed ID: 33972244
[TBL] [Abstract][Full Text] [Related]
32. Resistance to pyrazinamide in Russian Mycobacterium tuberculosis isolates: pncA sequencing versus Bactec MGIT 960.
Maslov DA; Zaĭchikova MV; Chernousova LN; Shur KV; Bekker OB; Smirnova TG; Larionova EE; Andreevskaya SN; Zhang Y; Danilenko VN
Tuberculosis (Edinb); 2015 Sep; 95(5):608-12. PubMed ID: 26071666
[TBL] [Abstract][Full Text] [Related]
33. Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China.
Che Y; Bo D; Lin X; Chen T; He T; Lin Y
BMC Infect Dis; 2021 Jun; 21(1):605. PubMed ID: 34171989
[TBL] [Abstract][Full Text] [Related]
34. Correlation between pyrazinamide activity and pncA mutations in Mycobacterium tuberculosis isolates in Taiwan.
Huang TS; Lee SS; Tu HZ; Huang WK; Chen YS; Huang CK; Wann SR; Lin HH; Liu YC
Antimicrob Agents Chemother; 2003 Nov; 47(11):3672-3. PubMed ID: 14576145
[TBL] [Abstract][Full Text] [Related]
35. Genotypic characterization of pyrazinamide resistance in Mycobacterium tuberculosis isolated from Lusaka, Zambia.
Bwalya P; Yamaguchi T; Mulundu G; Nakajima C; Mbulo G; Solo ES; Fukushima Y; Kasakwa K; Suzuki Y
Tuberculosis (Edinb); 2018 Mar; 109():117-122. PubMed ID: 29559115
[TBL] [Abstract][Full Text] [Related]
36. pncA mutations in clinical Mycobacterium tuberculosis isolates from Korea.
Park SK; Lee JY; Chang CL; Lee MK; Son HC; Kim CM; Jang HJ; Park HK; Jeong SH
BMC Infect Dis; 2001; 1():4. PubMed ID: 11429043
[TBL] [Abstract][Full Text] [Related]
37. Detection of pyrazinamide resistance of Mycobacterium tuberculosis using nicotinamide as a surrogate.
Hu Y; Wu X; Luo J; Fu Y; Zhao L; Ma Y; Li Y; Liang Q; Shang Y; Huang H
Clin Microbiol Infect; 2017 Nov; 23(11):835-838. PubMed ID: 28411185
[TBL] [Abstract][Full Text] [Related]
38. Mutations found in the pncA gene of Mycobacterium tuberculosis in clinical pyrazinamide-resistant isolates from a local region of China.
Zhang H; Bi LJ; Li CY; Sun ZG; Deng JY; Zhang XE
J Int Med Res; 2009; 37(5):1430-5. PubMed ID: 19930847
[TBL] [Abstract][Full Text] [Related]
39. Mutations in the pncA and rpsA genes among 77 Mycobacterium tuberculosis isolates in Kazakhstan.
Akhmetova A; Kozhamkulov U; Bismilda V; Chingissova L; Abildaev T; Dymova M; Filipenko M; Ramanculov E
Int J Tuberc Lung Dis; 2015 Feb; 19(2):179-84. PubMed ID: 25574916
[TBL] [Abstract][Full Text] [Related]
40. MODS-Wayne, a Colorimetric Adaptation of the Microscopic-Observation Drug Susceptibility (MODS) Assay for Detection of
Alcántara R; Fuentes P; Antiparra R; Santos M; Gilman RH; Kirwan DE; Zimic M; Sheen P
J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30429257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]